Blood Purification Equipment Market Research Report
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.1.1. Blood Purification Equipment Market
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Blood Purification Equipment Market Analysis and Forecast, 2018–2030
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Pricing Analysis
5.2. Technological Advancements
5.3. Epidemiology of Sepsis by Country/Region
5.4. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
5.5. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Blood Purification Equipment Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2018–2030
6.3.1. Dialysis
6.3.2. CRRT
6.3.3. Hemoperfusion
6.3.4. Others
6.4. Market Attractiveness Analysis, by Type
7. Global Blood Purification Equipment Market Analysis and Forecast, by Product Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Product Type, 2018–2030
7.3.1. Portable
7.3.2. Stationary
7.4. Market Attractiveness Analysis, by Product Type
8. Global Blood Purification Equipment Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Application, 2018–2030
8.3.1. Sepsis
8.3.2. COVID-19
8.3.3. Infectious Diseases
8.3.4. Acute Kidney Injury
8.3.5. Others
8.4. Market Attractiveness Analysis, by Application
9. Global Blood Purification Equipment Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2019–2030
9.3.1. Hospitals & Clinics
9.3.2. Dialysis Centers
9.3.3. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global Blood Purification Equipment Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Country/Region
11. North America Blood Purification Equipment Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value & Volume Forecast, by Type, 2018–2030
11.2.1. Dialysis
11.2.2. CRRT
11.2.3. Hemoperfusion
11.2.4. Others
11.3.Market Value Forecast, by Product Type, 2018–2030
11.3.1. Portable
11.3.2. Stationary
11.4.Market Value Forecast, by Application, 2018–2030
11.4.1. Sepsis
11.4.2. COVID-19
11.4.3. Infectious Diseases
11.4.4. Acute Kidney Injury
11.4.5. Others
11.5.Market Value Forecast, by End-user, 2018–2030
11.5.1. Hospitals & Clinics
11.5.2. Dialysis Centers
11.5.3. Others
11.6.Market Value Forecast, by Country, 2018–2030
11.6.1. U.S.
11.6.2. Canada
11.7.Market Attractiveness Analysis
11.7.1. By Type
11.7.2. By Product Type
11.7.3. By Application
11.7.4. By End-user
12. Europe Blood Purification Equipment Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value & Volume Forecast, by Type, 2018–2030
12.2.1. Dialysis
12.2.2. CRRT
12.2.3. Hemoperfusion
12.2.4. Others
12.3.Market Value Forecast, by Product Type, 2018–2030
12.3.1. Portable
12.3.2. Stationary
12.4.Market Value Forecast, by Application, 2018–2030
12.4.1. Sepsis
12.4.2. COVID-19
12.4.3. Infectious Diseases
12.4.4. Acute Kidney Injury
12.4.5. Others
12.5.Market Value Forecast, by End-user, 2018–2030
12.5.1. Hospitals & Clinics
12.5.2. Dialysis Centers
12.5.3. Others
12.6.Market Value Forecast, by Country/Sub-region, 2018–2030
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7.Market Attractiveness Analysis
12.7.1. By Type
12.7.2. By Product Type
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Blood Purification Equipment Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2.Market Value & Volume Forecast, by Type, 2018–2030
13.2.1. Dialysis
13.2.2. CRRT
13.2.3. Hemoperfusion
13.2.4. Others
13.3.Market Value Forecast, by Product Type, 2018–2030
13.3.1. Portable
13.3.2. Stationary
13.4.Market Value Forecast, by Application, 2018–2030
13.4.1. Sepsis
13.4.2. COVID-19
13.4.3. Infectious Diseases
13.4.4. Acute Kidney Injury
13.4.5. Others
13.5.Market Value Forecast, by End-user, 2018–2030
13.5.1. Hospitals & Clinics
13.5.2. Dialysis Centers
13.5.3. Others
13.6.Market Value Forecast, by Country/Sub-region, 2018–2030
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7.Market Attractiveness Analysis
13.7.1. By Type
13.7.2. By Product Type
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Blood Purification Equipment Market Analysis and Forecast
14.1.Introduction
14.1.1. Key Findings
14.2.Market Value & Volume Forecast, by Type, 2018–2030
14.2.1. Dialysis
14.2.2. CRRT
14.2.3. Hemoperfusion
14.2.4. Others
14.3.Market Value Forecast, by Product Type, 2018–2030
14.3.1. Portable
14.3.2. Stationary
14.4.Market Value Forecast, by Application, 2018–2030
14.4.1. Sepsis
14.4.2. COVID-19
14.4.3. Infectious Diseases
14.4.4. Acute Kidney Injury
14.4.5. Others
14.5.Market Value Forecast, by End-user, 2018–2030
14.5.1. Hospitals & Clinics
14.5.2. Dialysis Centers
14.5.3. Others
14.6.Market Value Forecast, by Country/Sub-region, 2018–2030
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7.Market Attractiveness Analysis
14.7.1. By Type
14.7.2. By Product Type
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Blood Purification Equipment Market Analysis and Forecast
15.1.Introduction
15.1.1. Key Findings
15.2.Market Value & Volume Forecast, by Type, 2018–2030
15.2.1. Dialysis
15.2.2. CRRT
15.2.3. Hemoperfusion
15.2.4. Others
15.3.Market Value Forecast, by Product Type, 2018–2030
15.3.1. Portable
15.3.2. Stationary
15.4.Market Value Forecast, by Application, 2018–2030
15.4.1. Sepsis
15.4.2. COVID-19
15.4.3. Infectious Diseases
15.4.4. Acute Kidney Injury
15.4.5. Others
15.5.Market Value Forecast, by End-user, 2018–2030
15.5.1. Hospitals & Clinics
15.5.2. Dialysis Centers
15.5.3. Others
15.6.Market Value Forecast, by Country/Sub-region, 2018–2030
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7.Market Attractiveness Analysis
15.7.1. By Type
15.7.2. By Product Type
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1.Market Player - Competition Matrix (by tier and size of companies)
16.2.Market Ranking Analysis, by Company, 2019
16.3. Company Profiles
16.3.1. Cytosorbents Europe GmbH
16.3.1.1.Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2.Product Portfolio
16.3.1.3.SWOT Analysis
16.3.1.4.Strategic Overview
16.3.2. Baxter
16.3.2.1.Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2.Product Portfolio
16.3.2.3.SWOT Analysis
16.3.2.4.Strategic Overview
16.3.3. Exthera Medical
16.3.3.1.Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2.Product Portfolio
16.3.3.3.SWOT Analysis
16.3.3.4.Strategic Overview
16.3.4. Aethlon Medical, Inc.
16.3.4.1.Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2.Product Portfolio
16.3.4.3.SWOT Analysis
16.3.4.4.Strategic Overview
16.3.5. Fresenius Medical Care
16.3.5.1.Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2.Product Portfolio
16.3.5.3.SWOT Analysis
16.3.5.4.Strategic Overview
16.3.6. Cerus Corp Company
16.3.6.1.Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2.Product Portfolio
16.3.6.3.SWOT Analysis
16.3.6.4.Strategic Overview
16.3.7. Jafron
16.3.7.1.Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2.Product Portfolio
16.3.7.3.SWOT Analysis
16.3.7.4.Strategic Overview
16.3.8. NxStage Medical, Inc.
16.3.8.1.Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2.Product Portfolio
16.3.8.3.SWOT Analysis
16.3.8.4.Strategic Overview
16.3.9. Spectral Medical, Inc.
16.3.9.1.Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2.Product Portfolio
16.3.9.3.SWOT Analysis
16.3.9.4.Strategic Overview
16.3.10. Kaneka Corporation
16.3.10.1.Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2.Product Portfolio
16.3.10.3.SWOT Analysis
16.3.10.4.Strategic Overview
16.3.11. B. Braun Melsungen AG
16.3.11.1.Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2.Product Portfolio
16.3.11.3.SWOT Analysis
16.3.11.4.Strategic Overview
16.3.12. Nikkiso Co, Inc.
16.3.12.1.Company Overview (HQ, Business Segments, Employee Strength)
16.3.12.2.Product Portfolio
16.3.12.3.SWOT Analysis
16.3.12.4.Strategic Overview
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers